Euroapi Company Header Euroapi Company Header

X

CAS 22246-18-0 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 22246-18-0
Also known as: 22246-18-0, 7-hydroxy-3,4-dihydroquinolin-2(1h)-one, 7-hydroxy-3,4-dihydro-2(1h)-quinolinone, 7-hydroxy-3,4-dihydro-1h-quinolin-2-one, 3,4-dihydro-7-hydroxycarbostyril, 7-hydroxy-3,4-dihydrocarbostyril
Molecular Formula
C9H9NO2
Molecular Weight
163.17  g/mol
InChI Key
LKLSFDWYIBUGNT-UHFFFAOYSA-N
FDA UNII
VFU6XCR3Q3

1 2D Structure

CAS 22246-18-0

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
7-hydroxy-3,4-dihydro-1H-quinolin-2-one
2.1.2 InChI
InChI=1S/C9H9NO2/c11-7-3-1-6-2-4-9(12)10-8(6)5-7/h1,3,5,11H,2,4H2,(H,10,12)
2.1.3 InChI Key
LKLSFDWYIBUGNT-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CC(=O)NC2=C1C=CC(=C2)O
2.2 Other Identifiers
2.2.1 UNII
VFU6XCR3Q3
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 22246-18-0

2. 7-hydroxy-3,4-dihydroquinolin-2(1h)-one

3. 7-hydroxy-3,4-dihydro-2(1h)-quinolinone

4. 7-hydroxy-3,4-dihydro-1h-quinolin-2-one

5. 3,4-dihydro-7-hydroxycarbostyril

6. 7-hydroxy-3,4-dihydrocarbostyril

7. 7-hydroxy-3,4-dihydro-quinolin-2-one

8. 3,4-dihydroquinoline-2,7-diol

9. 2(1h)-quinolinone, 3,4-dihydro-7-hydroxy-

10. Vfu6xcr3q3

11. Chembl2430711

12. Mfcd06410891

13. 3,4-dihydro-7-hydroxy-2(1h)-quinoline

14. 3,4-dihydro-7-hydroxyquinoline-2(1h)-one

15. 7-hydroxy-1,2,3,4-tetrahydroquinolin-2-one

16. 7-oxidanyl-3,4-dihydro-1~{h}-quinolin-2-one

17. 7-hydroxy-3,4-dihydro Carbostyril

18. Unii-vfu6xcr3q3

19. Aripiprazole Impurity 13

20. Aripiprazole Ep Impurity A

21. Schembl8751

22. Aripiprazole Impurity A [ep]

23. Dtxsid70382941

24. 7-hydroxy-3,4-dihydro-carbostyril

25. Bcp27862

26. Zinc3957997

27. Bbl011056

28. Bdbm50493470

29. S4767

30. Stk617335

31. Stk802230

32. Akos005551353

33. Akos005622540

34. Ab25068

35. Ac-7028

36. Ccg-266302

37. Cs-w010846

38. Fd18013

39. Gf-0122

40. Hy-w010130

41. Sy009657

42. 7-hydroxy-3,4-dihydro-1h-quinoline-2-one

43. 7-hydroxy-3,4-dihydro-2(1h)-quinolineone

44. 7-hydroxy-3,4-dihydro-quinolin-2(1h)-one

45. Am20060553

46. Aripiprazole Impurity A [ep Impurity]

47. D3599

48. Ft-0601230

49. 1,2,3,4-tetrahydroquinoline -7 -ol-2-one

50. 7-(hydroxyl)-3,4-dihydroquinolin-2(1h)-one

51. 7-hydroxy-1,2,3,4-tetrahydroquinoline-2-one

52. 7-hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline

53. 246h180

54. 3,4-dihydro-7-hydroxyquinolin-2(1h)-one

55. 3,4-dihydro-7-hydroxyquinoline-2(1h)-one-[d6]

56. 7-hydroxy-3,4-dihydro-2(1h)-quinolinone, 97%

57. A816050

58. J-511190

59. 7-hydroxy-3,4-dihydroquinolin-2(1h)-one;7-hydroxy-3,4-dihydro Carbostyril;7-hydroxy-3,4-dihydro-2(1h)-quinolinone;7-hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline;

60. 8hj

61. Aripiprazole Dihydro Quinolinone Impurity (usp); 7-hydroxycarbostyril; 3,4-dihydro-7-hydroxy-2(1h)-quinolinone; 7-hydroxy-3,4-dihydroquinolin-2(1h)-one

2.4 Create Date
2005-07-19
3 Chemical and Physical Properties
Molecular Weight 163.17 g/mol
Molecular Formula C9H9NO2
XLogP30.7
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count2
Rotatable Bond Count0
Exact Mass163.063328530 g/mol
Monoisotopic Mass163.063328530 g/mol
Topological Polar Surface Area49.3 Ų
Heavy Atom Count12
Formal Charge0
Complexity193
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag China
Digital Content Digital Content
URL Supplier Web Content
22246-18-0
Brexpiprazole
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY